Anemia of Chronic Disease

Snapshot

  • A 40-year-old woman with rheumatoid arthritis has felt tired and weak for several months. She attributed this to her autoimmune disease. However, in the past week, she has begun feeling very short of breath even walking to the grocery store; something she was able to do easily before. Her husband also noticed that she has been very pale. On physical exam, she has conjunctival pallor but an otherwise baseline physical exam. Laboratory results reveal anemia, decreased serum iron, increased ferritin, and decreased TIBC.

Introduction

image 2022 09 10T153839.671

  • Anemia of chronic disease resulting from decreased red blood cell production is a
    • normochromic, normocytic anemia
  • Pathogenesis
    • iron is stored in macrophages or bound with ferritin
    • hepcidin is an acute-phase reactant that is increased in states of inflammation 
      • inflammation causes release of hepcidin by the liver
      • ↑ hepcidin during inflammation 
        • binds ferroportin on intestinal mucosa, causing its internalization and degradation
          • inhibits iron absorption from diet
          • prevents release of iron bound by ferritin from macrophages
        • causes anemia
  • Associated conditions
    • chronic inflammatory condition 
    • chronic infection
    • longstanding malignancy
  • Prognosis
  • varied based on underlying inflammatory condition

Presentation

  • Symptoms of anemia
    • generalized weakness
    • fatigue
    • headache
    • shortness of breath
  • Physical exam
    • pallor
  • tachycardia

Evaluation

image 160
  • Labs 
    • ↑ ferritin
    • ↓ serum iron
    • ↓ TIBC, transferrin saturation, and MCV
  • Peripheral blood smears
    • normochromic RBCs
    • may be normocytic or microcytic
    • basophilic stippling
  • can be seen in alcohol abuse, lead poisoning, thalassemias, and hereditary pyrimidine 5′-nucleotidase deficiency

Differential Diagnosis

  • Anemia of renal disease 
  • Iron deficiency anemia 
  • Aplastic anemia 

Treatment

  • Treat underlying disease
  • If underlying disease is unknown or treatment of underlying disease does not improve symptomatic anemia
    • measure EPO
      • if low, administer EPO or erythropoiesis-stimulating agents (ESAs)
        • make sure iron stores (ferritin) are sufficient
  • if insufficient, patients may be resistant to EPO

Complications

  • Severe anemia